Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TARS will decline by -11.02% over the next 2 Weeks and hit $63.12 by Tuesday, February 3, 2026. In that time frame, TARS's share price is expected to range between $61.46 and $64.86.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 3, 2026 | 61.46 | 63.12 | 64.86 |
| Feb 2, 2026 | 62.65 | 64.20 | 65.88 |
| Jan 30, 2026 | 64.01 | 65.50 | 66.99 |
| Jan 29, 2026 | 65.38 | 66.81 | 68.22 |
| Jan 28, 2026 | 65.46 | 66.83 | 68.24 |
| Jan 27, 2026 | 65.66 | 67.02 | 68.42 |
| Jan 26, 2026 | 66.77 | 68.11 | 69.38 |
| Jan 23, 2026 | 68.03 | 69.40 | 70.71 |
| Jan 22, 2026 | 69.37 | 70.71 | 72.08 |
| Jan 21, 2026 | 69.37 | 70.74 | 71.96 |
TARS shares rose +0.34% in Wednesday, January 21, 2026's trading session, rising from a previous close of $70.93 to move at $71.17. The stock demonstrated notable intraday movement (see TARS's key stats for a full breakdown), fluctuating between $70.01 and $71.86, a +2.64% trading range. While recent weeks have seen some volatility, TARS has managed to secure a -10.90% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 731.79K shares changing hands, 436.63K fewer than the previous session. This amounted to $52.08M in total market activity.
Will TARS Continue Its Downward Trend?
According to analyst ratings and projections for TARS, Tarsus Pharmaceuticals, Inc. shares are anticipated to decrease by -9.73%, potentially reaching $64.86 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for TARS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the TARS stock forecast, now is not the best time to buy TARS stock because its current trading price is +12.76% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TARS covering social and institutional perspectives.
TARS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TARS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 16.90% to 35.45%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 50.43%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.00%, maintains a neutral outlook for the long term. Insights into TARS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Tarsus Pharmaceuticals Short-Term Forecasts
TARS Forecast For Next 5 Days
Our algorithm anticipates Tarsus Pharmaceuticals (TARS) stock could hit $67.23 by Jan 28, 2026. This represents a -5.54% fall from today's price, following a -6.09% change over the past five days.
TARS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Tarsus Pharmaceuticals, Inc. (TARS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $67.03, which would mean a -5.82% decrease from the current price of $71.17. Projections for this period range from a high of $73.49 to a low of $59.99.
TARS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Tarsus Pharmaceuticals's price over the next three months point to a rise. TARS stock is expected to peak at $78.86 on Mar 16, 2026 after potentially dipping to $65.57 on Feb 09, 2026. On average, TARS is likely to trade around $72.79 in the coming 90 days.
Tarsus Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Tarsus Pharmaceuticals (TARS) is expected to trade between $65.57 and $102.03 throughout 2026. This would result in an average price of $79.31, potentially offering investors a +11.44% return from current levels.
Tarsus Pharmaceuticals, Inc. Monthly Forecast 2026–2027
January 2026
According to our latest forecast models, Tarsus Pharmaceuticals, Inc. (TARS) is positioned to show a strong performance in January 2026. The price is predicted to move between $67.34 and $73.98, settling at an average of $70.63. This could translate to a -0.76% loss.
February 2026
Based on current market signals, Tarsus Pharmaceuticals, Inc. is projected to trend february 2026. We forecast a trading range from $65.57 to $76.30, with a likely average price of $71.00. Investors could expect a potential return of -0.24%.
March 2026
Our predictive algorithms indicate Tarsus Pharmaceuticals, Inc. stock may see a shift in March 2026. The expected range spans $70.63–$78.86, with an average target of $74.57. This represents a positive outlook and a possible gain of +4.78%.
April 2026
Analyzing established trends, Tarsus Pharmaceuticals, Inc. looks set to move in April 2026. Projections place the stock between $69.46 and $79.89, averaging around $74.59. This suggests a +4.81% gain from current levels.
May 2026
Market indicators suggest Tarsus Pharmaceuticals, Inc. could experience notable changes during May 2026. Prices could fluctuate within $72.08 to $80.60, with a midpoint forecast of $76.16. The stock might deliver a +7.01% gain.
June 2026
Forecasting for June 2026, models estimate that Tarsus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $73.80 and $82.43, averaging $78.34. This signals a positive trajectory with potential returns around +10.07%.
July 2026
According to our latest forecast models, Tarsus Pharmaceuticals, Inc. (TARS) is positioned to show a strong performance in July 2026. The price is predicted to move between $73.55 and $84.75, settling at an average of $78.90. This could translate to a +10.86% gain.
August 2026
Based on current market signals, Tarsus Pharmaceuticals, Inc. is projected to trend august 2026. We forecast a trading range from $78.39 to $86.49, with a likely average price of $82.18. Investors could expect a potential return of +15.47%.
September 2026
Our predictive algorithms indicate Tarsus Pharmaceuticals, Inc. stock may see a shift in September 2026. The expected range spans $77.10–$88.21, with an average target of $82.44. This represents a positive outlook and a possible gain of +15.84%.
October 2026
Analyzing established trends, Tarsus Pharmaceuticals, Inc. looks set to move in October 2026. Projections place the stock between $79.37 and $88.15, averaging around $83.70. This suggests a +17.61% gain from current levels.
November 2026
Market indicators suggest Tarsus Pharmaceuticals, Inc. could experience notable changes during November 2026. Prices could fluctuate within $82.02 to $102.03, with a midpoint forecast of $86.60. The stock might deliver a +21.68% gain.
December 2026
Forecasting for December 2026, models estimate that Tarsus Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $81.03 and $92.45, averaging $86.75. This signals a positive trajectory with potential returns around +21.89%.
January 2027
According to our latest forecast models, Tarsus Pharmaceuticals, Inc. (TARS) is positioned to show a strong performance in January 2027. The price is predicted to move between $86.32 and $93.68, settling at an average of $90.10. This could translate to a +26.60% gain.
TARS's history of dividends and stock splits also plays a role in long-term investor confidence.